Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-20 Sale | 2024-09-24 8:25 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 70,922 | $28.15 | $1,996,574 | 107,446 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:31 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 1,956 | $18.91 | $36,988 | 8,461 (Direct) | View |
| 2024-02-07 Sale | 2024-02-09 5:43 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 29,835 | $20 | $596,805 | 299,357 (Direct) | View |
| 2023-12-27 Sale | 2023-12-28 4:39 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 8,497 | $10.5 | $89,219 | 0 (Direct) | View |
| 2023-05-02 Sale | 2023-05-03 6:26 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 1,897 | $8.9049 | $16,893 | 16,982 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:42 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $9.7579 | $46,155 | 125,997 (Direct) | View |
| 2022-09-06 Sale | 2022-09-08 4:16 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $10.91 | $51,598 | 130,727 (Direct) | View |
| 2022-08-03 Sale | 2022-08-05 4:12 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 9,232 | $9.3069 | $85,921 | 248,015 (Direct) | View |
| 2022-07-05 Sale | 2022-07-07 4:23 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 9,232 | $8.3683 | $77,256 | 395,480 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 6:50 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 67,927 | $6.8299 | $463,935 | 607,580 (Direct) | View |
| 2022-06-13 Sale | 2022-06-15 6:39 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 26,381 | $6.0823 | $160,457 | 644,324 (Direct) | View |
| 2022-06-08 Sale | 2022-06-10 6:34 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 27,306 | $6.441 | $175,878 | 507,463 (Direct) | View |
| 2022-06-03 Sale | 2022-06-07 7:03 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 47,287 | $6.2593 | $295,985 | 797,815 (Direct) | View |
| 2022-05-16 Sale | 2022-05-18 5:15 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 10,800 | $7.4209 | $80,146 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-20 Exercise | 2024-09-24 8:25 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 70,922 | $0.71 | 107,446 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:25 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 70,922 | $0 | 107,446 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:31 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,208 | $0 | 8,461 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:43 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 29,835 | $0 | 299,357 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:43 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 29,835 | $1.93 | 299,357 (Direct) | View |
| 2023-08-17 Option Award | 2023-08-18 7:13 pm | N/A 2033-08-17 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-05-01 Exercise | 2023-05-03 6:26 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,208 | $0 | 16,982 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 4:42 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $0 | 125,997 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 4:42 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $1.93 | 125,997 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-08 4:16 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $0 | 130,727 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-08 4:16 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $1.93 | 130,727 (Direct) | View |
| 2022-08-08 Option Award | 2022-08-10 5:43 pm | N/A 2032-08-08 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-05 4:12 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,502 | $0.71 | 248,015 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-05 4:12 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 9,232 | $0 | 248,015 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-05 4:12 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $1.93 | 248,015 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-07 4:23 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,502 | $0.71 | 395,480 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-07 4:23 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 9,232 | $0 | 395,480 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-07 4:23 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 4,730 | $1.93 | 395,480 (Direct) | View |
| 2022-06-21 Exercise | 2022-06-21 6:50 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 13,508 | $0.71 | 607,580 (Direct) | View |
| 2022-06-16 Exercise | 2022-06-21 6:50 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 67,927 | $0 | 607,580 (Direct) | View |
| 2022-06-16 Exercise | 2022-06-21 6:50 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 54,419 | $1.93 | 607,580 (Direct) | View |
| 2022-06-13 Exercise | 2022-06-15 6:39 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 25,796 | $0.71 | 644,324 (Direct) | View |
| 2022-06-13 Exercise | 2022-06-15 6:39 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 26,381 | $0 | 644,324 (Direct) | View |
| 2022-06-15 Exercise | 2022-06-15 6:39 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 585 | $1.93 | 644,324 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 6:34 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 27,306 | $0.71 | 507,463 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 6:34 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 27,306 | $0 | 507,463 (Direct) | View |
| 2022-06-07 Exercise | 2022-06-07 7:03 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 17,150 | $0.71 | 797,815 (Direct) | View |
| 2022-06-03 Exercise | 2022-06-07 7:03 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 47,287 | $0 | 797,815 (Direct) | View |
| 2022-06-03 Exercise | 2022-06-07 7:03 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 30,137 | $1.93 | 797,815 (Direct) | View |
| 2022-05-01 Option Award | 2022-05-03 4:14 pm | N/A 2025-05-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 15,625 | $0 | 15,625 (Direct) | View |
| 2022-01-21 Exercise | 2022-01-25 6:50 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,400 | $0.71 | 217,684 (Direct) | View |
| 2022-01-21 Exercise | 2022-01-25 6:50 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,400 | $0 | 217,684 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:51 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,400 | $0.71 | 217,684 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:51 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,400 | $0 | 217,684 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 120,000 | $0 | 120,000 (Direct) | View |
Ownership | 2021-03-25 9:38 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 0 | $0 | 443,180 (Direct) | View |